The trusted data and intuitive software your organization needs to get pay right.
Explore CompAnalyst ®Get direct access to executive and director pay data extracted from proxy filings and annual reports for all US public companies.
Explore CompAnalyst ExecutiveGet access to aggregate nationwide compensation data immediately, including Salary.com's largest, most comprehensive compensation dataset.
Get Benchmark Job ReportAnkasa is developing ART352-L as a novel regenerative medicine. Successful development of ART352-L will enhance the osteogenic properties of patient derived stem cells used in reconstructive surgeries and provide safe and effective enhancement of bone formation in indications for which this is a significant unmet medical need. Ankasa's lead indication is augmentation of autograft used in spinal fu...